APA

Haji S. A., Starling R. C., Avery R. K., Mawhorter S., Tuzcu E. M., Schoenhagen P., Cook D. J., Ratliff N. B., McCarthy P. M., Young J. B. & Yamani M. H. (20040617). Donor hepatitis-C seropositivity is an independent risk factor for the development of accelerated coronary vasculopathy and predicts outcome after cardiac transplantation. : The Journal of heart and lung transplantation : the official publication of the International Society for Heart Transplantation.

Chicago

Haji Showkat A, Starling Randall C, Avery Robin K, Mawhorter Steven, Tuzcu E Murat, Schoenhagen Paul, Cook Daniel J, Ratliff Norman B, McCarthy Patrick M, Young James B and Yamani Mohamad H. 20040617. Donor hepatitis-C seropositivity is an independent risk factor for the development of accelerated coronary vasculopathy and predicts outcome after cardiac transplantation. : The Journal of heart and lung transplantation : the official publication of the International Society for Heart Transplantation.

Harvard

Haji S. A., Starling R. C., Avery R. K., Mawhorter S., Tuzcu E. M., Schoenhagen P., Cook D. J., Ratliff N. B., McCarthy P. M., Young J. B. and Yamani M. H. (20040617). Donor hepatitis-C seropositivity is an independent risk factor for the development of accelerated coronary vasculopathy and predicts outcome after cardiac transplantation. : The Journal of heart and lung transplantation : the official publication of the International Society for Heart Transplantation.

MLA

Haji Showkat A, Starling Randall C, Avery Robin K, Mawhorter Steven, Tuzcu E Murat, Schoenhagen Paul, Cook Daniel J, Ratliff Norman B, McCarthy Patrick M, Young James B and Yamani Mohamad H. Donor hepatitis-C seropositivity is an independent risk factor for the development of accelerated coronary vasculopathy and predicts outcome after cardiac transplantation. : The Journal of heart and lung transplantation : the official publication of the International Society for Heart Transplantation. 20040617.